X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmaceutical-technology.com/news/cellenkos-mount-ck0804/
https://www.prnewswire.com/news-releases/cellenkos-approved-to-proceed-with-ck0803-neurotrophic-t-regulatory-cell-therapy-to-treat-second-cohort-in-als-trial-302064780.html
https://www.clinicaltrialsarena.com/news/cellenkos-first-patient-sclerosis-trial/
https://www.prnewswire.com/news-releases/cellenkos-announces-first-patient-dosed-with-ck0803-cell-therapy-for-treatment-of-amyotrophic-lateral-sclerosis-301812682.html
https://www.prnewswire.com/news-releases/global-cord-blood-corporation-announced-cellenkos-receives-fda-clearance-of-ind-application-for-ck0804-as-add-on-therapy-to-ruxolitinib-for-the-treatment-of-myelofibrosis-301569662.html
https://www.contractpharma.com/contents/view_breaking-news/2021-06-22/cellenkos-chooses-cryoport-to-support-covid-19-therapy-shipments-to-patients/?widget=listSection
https://www.businesswire.com/news/home/20201230005038/en/Incyte-and-Cellenkos-Enter-into-Global-Development-Collaboration-Agreement-for-CK0804
https://www.prnewswire.com/in/news-releases/cellenkos-r-inc-announces-fda-clearance-to-initiate-phase-1-double-blinded-randomized-placebo-controlled-trial-of-cryopreserved-cord-blood-derived-t-regulatory-cells-ck0802-for-treatment-of-covid-19-associated-acute-respiratory-distress-syn-891362475.html
Market Place
Share 
